HomeExpand-TB
In 2009, UNITAID approved funding for a project to accelerate access to diagnostics for patients at risk of multidrug-resistant tuberculosis in 27 countries (see figure below). The EXPAND-TB (Expanding Access to New Diagnostics for TB) Project is the result of a successful collaboration between the World Health Organization (WHO), the Global Laboratory Initiative (GLI), the Foundation for Innovative New Diagnostics (FIND) and the Stop TB Partnership Global Drug Facility (GDF).
The EXPAND-TB Project aims to diagnose at least 115,213 patients with multidrug-resistant TB. Specific operational objectives are to:
Practical Guide to Implementation of Truenat tests
Practical implementation of LF-LAM for detection of active TB in people living with HIV
GLI TB Laboratory Safety Handbook
Practical considerations for implementation of the Abbott RealTime MTB and Abbott RealTime MTB RIF/INH tests
Practical considerations for implementation of the BD MAX MDR-TB test
Practical considerations for implementation of the Roche cobas MTB and cobas MTB-RIF/INH assays
Practical considerations for implementation of the Bruker-Hain Lifesciences FluoroType MTB and FluoroType MTBDR
Practical considerations for implementation of the Cepheid Xpert MTB/XDR test
Practical considerations for implementation of the Nipro Genoscholar PZA-TB II assay
Practical considerations for implementation of the loop-mediated isothermal amplification (TB-LAMP) test